Leukaemia drug gets initial 'no' for NHS in England
Patients living with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for use on the NHS in England.
Mar 8, 2019
0
1
Patients living with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for use on the NHS in England.
Mar 8, 2019
0
1
A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...
Mar 7, 2019
0
1
Leukaemia promotes premature ageing in healthy bone marrow cells—according to new research from the University of East Anglia.
Jan 30, 2019
1
79
A mechanism which drives leukaemia cell growth has been discovered by researchers at the University of Sussex, who believe their findings could help to inform new strategies when it comes to treating the cancer.
Jan 16, 2019
0
9
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.
Dec 11, 2018
0
29
Scientists are hoping to develop a new generation of therapies to tackle acute myeloid leukaemia, a type of blood cancer which is particularly difficult to treat.
Nov 6, 2018
0
1
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.
Sep 25, 2018
0
121
People with a slow developing type of blood cancer may be able to safely come off 'life-long' daily treatment in the future and remain free from cancer, the latest results from a University of Liverpool clinical trial suggest.
Jun 27, 2018
0
29
The overproduction of the BCL-2 protein is due to a defect in the ribosome, the protein factory of the cell. This defect is found in 10% of the pediatric patients with T-cell leukaemia.
Jun 26, 2018
0
0
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Jun 20, 2018
0
100